The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP).

The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports ...

“This connection may involve genetic factors that influence how the body responds to the virus and its aftermath, ...

DelveInsight's D-Dimer Testing Market Insights report provides the current and forecast market analysis, individual leading D ...

Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

The patient had been suffering from hard-to-control diabetes despite intensive insulin treatment and had received a pancreas ...

The growing prevalence of cardiovascular and thrombotic disorders is driving strong demand for D-dimer testing. As blood clot-related risk factors continue to increase, the need for precise ...

As described in previous updates, we have been working closely with FDA regarding the anticipated resubmission of our Biologics License Application, or BLA for narsoplimab in hematopoietic stem cell ...